2 on Zn absorption was investigated in MT-null (MTϪ/Ϫ) and normal (MTϩ/ϩ) mice fed Zn-depleted (ZnD) diets for 7 d and compared with those fed Zn-replete (ZnR) diets in a previous study. Mice were starved for 20 h, then administered an oral gavage of aqueous 65 ZnSO 4 solution at doses of 154, 770 or 1540 nmol of Zn, and the amount transferred into nongut tissues was determined 4 h later. 65 Zn transfer did not differ between genotypes in ZnR mice. However ZnD MTϩ/ϩ mice had a 30 -40% greater transfer from the 154 and 770 Zn doses compared to ZnR MTϩ/ϩ mice. This was not observed in MTϪ/Ϫ mice. In MTϩ/ϩ mice, Zn depletion enhanced the induction of MT by Zn in the intestine and pancreas. 65 Zn uptakes in the liver and pancreas were greater in MTϩ/ϩ than MTϪ/Ϫ mice, and this was greater (50%) at the 154 and 770 doses in mice fed ZnD diets. Plasma Zn concentrations were raised to a similar extent in ZnR and ZnD MTϪ/Ϫ mice. ZnR MTϩ/ϩ mice had significantly lower plasma Zn levels than MTϪ/Ϫmice; this difference was less marked in the ZnD mice. We conclude that a MT-facilitated enhancement in Zn absorption occurs in response to dietary Zn deficiency. J. 
Zn absorption is primarily influenced by the amount ingested, physicochemical interaction of binding ligands in liquid and food, gut regional pH, retention by the glycocalyx, gastric emptying and intestinal transit rate (Whitehead et al. 1996) . Part of the complex gut dynamics are underlying paracellular and transcellular Zn-transport processes that are thought to take place primarily in the upper small intestine (Lönnerdal 1989) . There is substantial evidence supporting the view that Zn absorption is in part facilitated by carriermediated processes (Cousins 1985 , Lönnerdal 1989 . Despite intensive research, however, the interrelationships between the ligands that facilitate the uptake, secretion and transport of Zn across the intestinal wall are only now being unraveled. In yeast, high-and low-affinity Zn transporters have been identified which have concentrations regulated by extracellular Zn, both by transcriptional regulation of the transporter protein genes and by control of the rate of degradation of the protein itself (Gitan et al. 1998) . Another family of Zn transporters (ZnT-1 to 2 has been described in rodents, providing compelling evidence for carrier-mediated Zn transport in eukaryotes (Huang and Gitschier 1997 , Palmiter et al. 1996 a,b, ,Palmiter and Findley 1995 . ZnT-1 in particular, has been located in the basolateral membrane of the small intestine; its mRNA has been shown to be increased by high dietary Zn, and it appears to be essential for Zn efflux from enterocytes . Transporters controlling the influx of Zn, however, remain elusive. Recently, an iron transporter protein, namely divalent cation transporter -1, with a broad specificity for other metals including Zn, has been characterized (Gunshin et al. 1997 ). DCT-1 mRNA level has been found to be highest in duodenal crypts, and its expression is increased in iron deficiency. Whether the expression of DCT-1 is influenced by deficiency of other divalent cations such as Zn remains to be demonstrated.
Mucosal-to-luminal secretion of endogenous Zn may occur simultaneously with Zn absorption and also contribute to luminal Zn concentration and hence bioavailability (Evans et al. 1979 , Flanagan et al. 1983 , Hoadley et al. 1988 ). Many studies have demonstrated enhanced efficiency of Zn absorption in ZnD animals (Flanagan et al. 1983 , Hoadley et al. 1988 , Jackson et al. 1981 , Smith and Cousins 1980 , Weigand and Kirchgessner 1980 . It has been argued that this may result from increased absorption at low Zn intakes, decreased secretion of endogenous Zn or a balance between the two (Lön-nerdal 1989) . Control of Zn homeostasis appears to speciesspecific, with absorption being regulated more than secretion in rats but just the opposite in mice (Flanagan et al. 1983) .
Induction of metallothionein (MT) synthesis in mucosal cells is triggered by both fasting and high luminal zinc concentrations but is not significantly induced at normal dietary zinc intakes (Cousins 1985 , Tran et al. 1998 . Additionally, pancreatic Zn secretion is an important component of Zn homeostasis, and we have recently shown that MTϪ/Ϫ mice sequester less Zn in the pancreas and secrete more into the intestinal lumen . There was clear demonstration of increased pancreatic secretion in MTϪ/Ϫ mice, although increased mucosal-to-luminal secretion could not be ruled out.
The relative contribution of intestinal MT to Zn absorption and secretory processes is contentious (Evans et al. 1979 , Hoadley et al. 1988 , Starcher et al. 1980 ). Evans and coworkers (1979) did not find a role for MT in Zn absorption, whereas others have found that MT can facilitate Zn absorption when dietary Zn is limited (Hoadley et al. 1988) . It has also been argued that when there is excess Zn in the diet, MT sequesters Zn in the intestinal wall, thereby transiently reducing the absorption of Zn and favoring Zn transfer back into the gut lumen (Cousins 1985 , Lönnerdal 1989 . More recently Davis and coworkers (1998) found that MT knockout mice had higher intestinal Zn content than mice which overexpress MT after being given intragastric Zn, indicating that MT does not reduce Zn absorption solely by sequestering Zn in the mucosa.
Recently we found that Zn absorption was the same in normal and MTϪ/Ϫ mice fed a ZnR diet and given an intragastric dose of Zn in aqueous solution . The presence of MT, however, conferred an absorptive advantage when Zn was given in solid food. This may indicate that intestinal MT aids in sequestering Zn when it is present in the lumen either attached to food-ligands or when Zn supply is limited. Whether MT plays a role in Zn absorption in ZnD mice has not been examined. In this report, we examine the influence of MT on Zn absorption in ZnD mice by determining the uptake of 65 Zn in normal and MTϪ/Ϫ mice fed ZnD diets for 7 d.
MATERIALS AND METHODS
MTϪ/Ϫ mice were F3 derivatives of the interbreeding of MTϩ/ϩ C57BL6 (Animal Resources Center, Canning Vale, Western Australia) and MTϪ/Ϫ mice produced at the Murdoch Institute, Royal Children's Hospital, Victoria, Australia (Michalska and Choo 1993) . The latter were of mixed genetic background of OLA129 and C57BL6 strains. The genotypes of the F2 mice were established by DNA analysis of tail-tip samples using the technique described by Michalska and Choo (1993) . Mice were housed in plastic cages with stainless steel wire floors: 45 cm x 16 cm, 7.5 mm mesh, 1 mm wire diameter to prevent coprophagy, in an animal house at 22°C with a 14-h light/10-h dark cycle. Weight and sex matched mice from each genotype were housed together for 7 d in groups of eight and given free access to water and a ZnD purified diet . In this study, we compare the results on ZnD mice with our previously published study on ZnR mice ). The ZnD and ZnR studies were conducted within a 6-mo period with several overlapping experiments. Mice used in both studies were from cohorts derived from the same parents. The 65 Zn, carrier-Zn and experimental protocols were the same in both studies. The Zn concentrations of the ZnR and ZnD diets as determined by atomic absorption spectrometry were 100 and 0.8 Zn mg/kg, respectively. After 7 d of consuming these diets, plasma Zn concentrations were 11.5 Ϯ 0.7 and 13.0 Ϯ 1.4 mol/L in four ZnR MTϩ/ϩ and MTϪ/Ϫ mice, respectively, and 7.7 Ϯ 0.3 and 10.7 Ϯ 0.3 in five mice fed ZnD diets.
65
Zn Absorption in MT؉/؉ and MT؊/؊ mice. Mice (weight after food deprivation: ZnR, 22.9 Ϯ 0.3 g; ZnD, 21.5 Ϯ 0.2 g) were starved for 20 h prior to oral gavage with 0.1 mL of 65 Zn (37 kBq; NEN Life Science Products, Boston, MA) containing 154, 770 or 1540 nmol [10, 50 or 100 g, respectively,] of Zn as ZnSO 4 . Four hours later, blood was taken from each mouse by cardiac puncture under light halothane anesthesia before killing by cervical luxation. The carcass was carefully dissected and staged to avoid cross-contamination with 65 Zn. A 4-cm 2 sample of skin and a 200-mg portion of abdominal muscle were taken first. The gastrointestinal tract from stomach to colon was removed and divided into six segments viz: stomach; proximal, middle and distal thirds of the small intestine; cecum; and colon. The three segments of small intestine were immediately subjected to gamma counting. The lumens were then flushed with normal saline to remove the contents and the washed segments counted again (within 20 min of the initial counting) to determine the 65 Zn uptake by the gut wall. The heart, liver, kidneys, spleen, testes and brain were excised. Radioactivity was determined in the tissue samples using a cassette-fed Packard Auto-Gamma Counter, model 5650 (Canberra-Packard, Melbourne, Australia).
The term "Zn transfer" is defined here as the fraction of 65 Zn absorbed from the gavaged dose into all nongut tissues. It is the sum of the 65 Zn uptakes of nongut tissues expressed as a percentage of the oral 65 Zn dose. The total 65 Zn associated with whole blood, plasma, skin and muscle was calculated as follows:
Percentage of oral dose ϭ Bq per g of tissue ϫ tissue wt as a fraction of body wt ϫ body wt (g) Bq in dose ϫ 100
The fractions of body weight used were 0.33 for muscle, 0.13 for skin, 0.07 for whole blood and 0.035 for plasma. Liver, pancreas and small intestine were chilled on crushed ice, counted without delay, and then homogenized in 10 mmol/L of Tris buffer pH 7.4 using an Ultra-Turrax homogenizer, and MT was determined by a Cd/Heme assay [modified from Eaton and Toal (1982) ]. Plasma Zn concentrations were determined by atomic absorption spectrometry. Statistical analyses. Three-way ANOVA using the general linear model on Minitab (Minitab State College, PA) was used for comparison of differences between means for factors of genotype (MTϩ/ϩ or MTϪ/Ϫ), diets (ZnR or ZnD) and oral Zn dose (154, 770 or 1540 nmol). Because absorption data had already been normalized by expression as percentage uptake, no further transformation of data was undertaken before ANOVA. Variability is expressed as the root mean square error, an estimate of the SD across treatments. When interactions were significant, the post-hoc test of Tukey was used to distinguish differences between specific means (Tukey 1949) . Where appropriate, data are expressed as the mean Ϯ SEM and differences assessed by two-tailed unequal variance Student's t test. Differences were considered significant at P Ͻ 0.05. Text references state the highest P-value obtained.
This work was approved by the Institute of Medical and Veterinary Science Animal Ethics Committee.
RESULTS
Zn Absorption in MT؉/؉ and MT؊/؊ mice. Plasma Zn increased in proportion to the oral Zn dose and in MTϪ/Ϫ mice was approximately double that in MTϩ/ϩ mice gavaged with the highest Zn dose. Plasma Zn levels were significantly higher in MTϩ/ϩ mice fed the ZnD than those fed the ZnR diet when gavaged the two highest Zn doses and in MTϪ/Ϫ mice fed ZnD, gavaged with 770 nmol of Zn. In order to determine the body distribution of Zn, the uptake of 65 Zn was determined in various tissues 4 h after intragastric gavage, and the results are presented in Table 1 . The recovery of the oral dose, including that in the gastrointestinal tract, was 96.3 Ϯ 0.9% (n ϭ 131).
The transferred dose of 65 Zn is here defined as the percentage of the oral dose retained by the body, excluding that in the gastrointestinal tract. The transferred dose of 65 Zn was inversely proportional (r ϭ Ϫ0.9229, P Ͻ 0.01) to the amount of Zn present in the gavaged dose. There was no difference in transferred dose between MTϩ/ϩ and MTϪ/Ϫ mice fed either diet. However, 65 Zn transfer in MTϩ/ϩ mice fed the ZnD diet was 30% and 40% higher than their MTϩ/ϩ counterparts fed the ZnR diet and gavaged with 154 and 770 nmol of Zn, respectively. No incremental increase in 65 Zn transfer was observed in MTϪ/Ϫ mice fed the ZnD diet.
The uptake of 65 Zn and the relative effects of both genotype and diet varied between tissues. Diet and genotype affected Mice were given free access to a purified diet for 7 d containing either 0.7 mg of Zn/kg (Zn-deficient: ZnD) or 100 mg of Zn/kg (Zn-replete: ZnR). They were then deprived of food for 20 h then gavaged with 0.1 mL of 65 Zn (37 kBq) in selected amounts of ZnSO 4 .
3 ZnR results were previously published . 4 RMSE ϭ root mean square error and is an estimate of the overall standard deviation. 5 ANOVA using the factors diet (ZnR or ZnD), genotype (MTϩ/ϩ or MTϪ/Ϫ) and oral Zn dose (154, 770, 1540 nmol). Factorial ANOVA abbreviations: Diet, main effect; Gt, genotype, main effect; Zn, oral Zn dose, main effect; Diet ϫ Gt, Diet ϫ genotype, interaction, main effect; Diet ϫ Zn, Diet ϫ oral Zn dose, interaction, main effect; Gt ϫ Zn, genotype ϫ oral Zn dose, interaction, main effect Diet ϫ Gt ϫ Zn, Diet ϫ genotype ϫ oral Zn dose, interaction. Only main effects with P Ͻ 0.05 are shown.
6 Plasma Zn concentrations were determined by atomic absorption spectrometry. 7 Transferred dose is the total sum of the portions of the dose in whole blood, muscle, skin, liver, kidneys, spleen, heart, lungs, testes, brain, pancreas and urine. The sum of the values obtained in the spleen, lungs, testes and urine were Ͻ0.5% and individually were similar between diets and genotypes. In muscle and skin, 65 Zn uptakes were higher in MTϪ/Ϫ than MTϩ/ϩ mice gavaged with 1540 nmol of Zn. In muscle, 65 Zn levels were one-third greater in mice of both genotypes fed ZnD than ZnR at a Zn dose of 154 nmol and in MTϩ/ϩ mice gavaged with 770 nmol Zn. The uptake of 65 Zn by skin was also higher in MTϪ/Ϫ mice fed ZnD than ZnR at the lowest oral Zn dose. In heart, 65 Zn levels were 38 and 53% higher in MTϪ/Ϫ mice than in MTϩ/ϩ mice fed the ZnR diet for doses of 770 and 1540 nmol of Zn, respectively, and were greater in MTϪ/Ϫ mice fed the ZnD diet compared with those fed the ZnR diet at 154 nmol of Zn. Likewise in brain, MTϪ/Ϫ mice had higher uptakes than MTϩ/ϩ mice when gavaged with 154 nmol of Zn regardless of diet, or when gavaged with 1540 nmol of Zn and fed the ZnR diet. Brain 65 Zn levels were greater in mice of both genotypes fed ZnD than ZnR diet and gavaged with 154 nmol Zn, and in MTϩ/ϩ mice gavaged with the highest Zn dose.
Liver 65 Zn levels were unaffected by diet. 65 Zn uptake in the liver of MTϩ/ϩ mice was 47 and 119% higher than MTϪ/Ϫ mice when fed the ZnD diet and gavaged with 154 and 770 nmol of Zn, respectively. Likewise, the pancreatic uptake of 65 Zn was unaffected by diet but was different between genotypes. Pancreatic uptakes in MTϩ/ϩ mice were 50 -140% higher than MTϪ/Ϫ mice, gavaged with 154 nmol of Zn, and 55% higher in those mice fed the ZnD diet and gavaged with 770 nmol of Zn. The uptake of 65 Zn by kidneys, spleen and lungs (the latter two not shown) were unaffected by diet or genotype.
In summary, at the lower Zn doses, 65 Zn uptake was generally higher in blood, muscle, skin, heart and brain of MTϩ/ϩ and MTϪ/Ϫ mice fed the ZnD compared with the ZnR diets. In addition, MTϪ/Ϫ mice had higher 65 Zn uptakes in those individual tissues than their MTϩ/ϩ counterparts. In contrast, liver and pancreas had higher 65 Zn uptakes in MTϩ/ϩ mice regardless of diet. The transferred dose, which is an estimate of the combined intertissue changes, showed higher 65 Zn uptakes in MTϩ/ϩ mice fed the ZnD diet primarily because of the increased levels in liver and pancreas.
The radioactivity remaining in the gut wall and contents 4 h after intragastric dosing with 65 Zn was determined ( Table  2) . Very little radioactivity was found in the stomach, and this did not differ due to diet, genotype or oral Zn doses. The fraction of the dose retained in the upper two-thirds of the small intestine was inversely proportional to the oral Zn dose but not affected by diet or genotype. The counts retained in the ileum were mainly greater in MTϪ/Ϫ (36.3 Ϯ 2.5% of 65 Zn dose) than MTϩ/ϩ mice (17.0 Ϯ 1.7% of 65 Zn dose), and there was a correspondingly lower 65 Zn level in the cecum and colon in the former. On average, the washed ileal wall retained ϳ50% of the counts in the combined wall and contents, and reflected the same effect of genotype, with higher 65 Zn levels found in MTϪ/Ϫ than MTϩ/ϩ mice. The counts in the ileum ϩ cecum ϩ colon were 67.1 Ϯ 1.2% of the oral dose, and were the same for both diet and genotype. In summary, the findings indicate that approximately the same bolus of 65 Zn reaches the distal small intestine, cecum and colon regardless of genotype, but MTϪ/Ϫ mice had proportionally more counts in the ileum than in the large bowel, suggesting that they have a slower intestinal transit than MTϩ/ϩ mice. Nonetheless, at 4 h, the majority of the oral dose had passed the main absorptive region of the small intestine in both genotypes.
The following concentrations of "MT" were found in MTϪ/Ϫ mice 4 h after intragastric dosing with 770 nmol of Zn: small intestine ZnR, 2.1 Ϯ 0.1(n ϭ 13); ZnD, 2.7 Ϯ 0.5 (n ϭ 3), liver ZnR, 3.0 Ϯ 0.1 (n ϭ 4); ZnD, 2.9 Ϯ 0.3 (n ϭ 3) and pancreas ZnR, 2.3 Ϯ 0.1; ZnD, 1.9 Ϯ 0.1 (n ϭ 3). We consider that these levels represent the noise threshold, which is nonspecific binding of 109 Cd to heat-stable ligands other than MT in the assay. In MTϩ/ϩ mice (Fig. 1a) , liver MT was directly proportional to the oral Zn dose [ZnR, y ϭ 0.021x ϩ 15.2; r ϭ 0.995, ZnD; y ϭ 0.018x ϩ 22.1; r ϭ 0.998, where y ϭ MT (nmol Cd bound/g wet liver) and x ϭ Zn dose (nmol)]. There was no effect of diet on liver MT at any of the oral Zn doses.
MT concentrations in the small intestine of MTϩ/ϩ mice were proportional to the oral Zn dose [ZnR, y ϭ 0.010x ϩ 23.0; r ϭ 0.991, ZnD; y ϭ 0.026x ϩ 17.3; r ϭ 0.999, where y ϭ MT (nmol Cd bound/g wet intestine) and x ϭ Zn dose (nmol)] (Fig. 1B) . Small intestine MT of mice fed the ZnD diet was more responsive to the oral Zn dose, being 48% higher than levels in mice fed the ZnR diet when gavaged with a 1540 nmol of Zn.
Pancreatic MT concentrations were proportional to the oral Zn dose [ZnR, y ϭ 0.026x ϩ 119.5; r ϭ 0.905, ZnD; y ϭ 0.103x ϩ 62.2; r ϭ 0.989, where y ϭ MT (nmol Cd bound/g wet pancreas) and x ϭ Zn dose (nmol)] (Fig. 1C) . MT levels in the pancreas of mice fed ZnD diets were more responsive to the oral Zn dose than those fed ZnR diets. In the ZnD group, MT values were 33% lower than their ZnR counterparts when gavaged with 154 nmol of Zn and 38% higher with the highest oral dose.
DISCUSSION
Discussion of Zn absorption in MTϩ/ϩ and MTϪ/Ϫ mice fed ZnR diets has been presented in a previous report . Maintenance of Zn homeostasis during periods of Zn depletion by regulating the efficiency of Zn absorption has been questioned. Many earlier studies using orally administered 65 Zn to demonstrate regulation of Zn absorption have been criticized because of poor experimental design. In particular, it has been argued that endogenous Zn present in the lumen of the small intestine may have affected the specific activity of the 65 Zn, resulting in the wrong conclusions being drawn as to the amount of Zn absorption (Flanagan et al. 1983 ). These investigators controlled for endogenous Zn levels in the small intestine and found that in rats but not in mice, intestinal Zn absorption increased in response to dietary Zn deficiency. Our findings with mice do not support theirs and demonstrate that, like rats, ZnD mice absorb proportionally more Zn from an intragastric dose than ZnR mice, which is consistent with the premise that Zn homeostasis is in part maintained by regulation of Zn absorption.
The endogenous Zn levels in the absorptive region of the small intestinal lumen were determined in mice fed ZnR or ZnD diets for 7 d, starved for 20 h, but gavaged with water rather than radioactive Zn. The total Zn (nmol) in the luminal contents in the duodenum-jejunum (ZnR: MTϩ/ϩ, 8.0 Ϯ 2.0, MTϪ/Ϫ, 6.0 Ϯ 1.2. ZnD: MTϩ/ϩ, 7.4 Ϯ 0.9, MTϪ/Ϫ 13.2 Ϯ 2.3) and jejunum-ileum (ZnR: MTϩ/ϩ, 9.3 Ϯ 1.7, MTϪ/Ϫ, 8.1 Ϯ 1.0. ZnD: MTϩ/ϩ, 11.1 Ϯ 2.9, MTϪ/Ϫ, 13.2 Ϯ 2.0) were not significantly different among groups. Thus, differences in the specific activity of 65 Zn between ZnR and ZnD are too small to influence comparisons, particularly at the 770 nmol Zn dose. It could be argued that Flanagan and coworkers (1983) used a lower oral Zn dose of 100 nmol, rendering their absorption measurements more susceptible to differences in endogenous Zn.
In the present study, 65 Zn transfer into nongut tissues was 30 and 40% higher in ZnD MTϩ/ϩ mice than in their ZnR counterparts given the low and normal Zn doses. While the increased efficiency of Zn absorption was significant only in MTϩ/ϩ mice, there was nonetheless, no significant difference between genotypes fed the ZnD diet. MTϪ/Ϫ mice fed the ZnD diet and gavaged with the lowest Zn dose had significantly higher plasma Zn concentrations and greater Zn uptakes in blood, muscle, skin, heart and brain than those fed ZnR diets. These findings indicate that Zn absorption may be Values represent the means (n ϭ 6-28), expressed as a percentage of the original 65 Zn dose retained in the tissues at 4 h. 2 Mice were given free access to a purified diet for 7 d containing either 0.7 mg of Zn/kg (Zn-deficient: ZnD) or 100 mg of Zn/kg (Zn-replete: ZnR). They were then deprived of food for 20 h then gavaged with 0.1 mL of 65 Zn (37 kBq) in selected amounts of ZnSO 4 .
3 The radioactivity was determined in the segment of gut and contents. 4 ZnR results were previously published . 5 The contents of the gut segment were removed by flushing the lumen with saline before the radioactivity in the gut wall was determined. 6 RMSE ϭ root mean square error and is an estimate of the overall standard deviation. 7 ANOVA using the factors diet (ZnR or ZnD), genotype (MTϩ/ϩ or MTϪ/Ϫ) and oral Zn dose (154, 770, 1540 nmol) . Factorial ANOVA abbreviations: Diet, main effect; Gt, genotype, main effect; Zn, oral Zn dose, main effect; Diet ϫ Gt, Diet ϫ genotype, interaction, main effect; Diet ϫ Zn, Diet ϫ oral Zn dose, interaction, main effect; Gt ϫ Zn, genotype ϫ oral Zn dose, interaction, main effect Diet ϫ Gt ϫ Zn, Diet ϫ genotype ϫ oral Zn dose, interaction. Only main effects with P Ͻ 0.05 are shown.
a Significantly different from mice of that genotype fed the same diet and gavaged with 154 nmol of Zn at P Ͻ 0.05. b Significantly different from mice of that genotype fed the same diet and gavaged with 770 nmol of Zn at P Ͻ 0.05. c Significantly different from mice fed a Zn-replete diet and gavaged with same amount of Zn at P Ͻ 0.05. d Significantly different from MTϩ/ϩ mice fed the same diet gavaged with same amount of Zn at P Ͻ 0.05.
augmented by an MT independent process in ZnD mice at lower dietary Zn intakes. While mechanisms for Zn uptake await elucidation in eukaryotes, a saturable high-affinity transporter that is active in Zn limited cells and a low-affinity transporter which works in ZnR cells have been characterized in yeast (Gitan et al. 1998 ). These transporter proteins are both transcriptionally and post-translationally regulated by Zn. In eukaryotes, a saturable iron transporter protein, DCT-1, is increased in iron deficiency and has broad specificity for other metals including Zn (Gunshin et al. 1997) . A Zn-specific transporter that is upregulated in ZnD states remains to be found. Although the transferred dose was the same in MTϩ/ϩ and MTϪ/Ϫ mice fed ZnD diets, there were significant intergenotype differences in 65 Zn distribution among tissues. In general, at one or more of the oral Zn doses, 65 Zn uptakes were greater in blood, muscle, skin and brain in MTϪ/Ϫ than MTϩ/ϩ mice. In liver and pancreas, however, the relative uptakes were reversed with greater uptakes in MTϩ/ϩ than MTϪ/Ϫ mice. Similar differential uptakes in tissues between genotypes have followed the systemic injection of 65 Zn ). Increased Zn uptake by liver and pancreas in MTϩ/ϩ mice paralleled increased MT accumulation in these tissues. In liver, MT accumulation in MTϩ/ϩ mice fed ZnD and given 154 or 770 nmol of Zn represents the stoichiometric incorporation of ϳ22 and 32 nmol of Zn/g (liver wt 0.96 Ϯ 0.02 g, n ϭ 29), respectively. This accumulation of MT is sufficient to account for all of the extra Zn (2.6% of 154 nmol and 3.9% of the 770 nmol, oral Zn dose) found in the liver of MTϩ/ϩ mice compared to that in MTϪ/Ϫ mice fed the ZnD diet. In the pancreas, there was only a small increase in MT accumulation in MTϩ/ϩ mice fed ZnR diets but a greater increase in those fed ZnD diets. In the latter, MT levels were ϳ200 nmol/g, which represents the stoichiometric incorporation of ϳ40 nmol of Zn (pancreas wt 0.20 Ϯ 0.01 g, n ϭ 29). Thus, the dose-related increase of MT in the pancreas of mice fed ZnD diets was sufficient to account for the increase in Zn uptake (1-2% of lowest two oral Zn doses) compared to that in MTϪ/Ϫ mice fed the same diet.
This study also demonstrates that, in the small intestine, pancreas and liver, MT synthesis is proportional to the oral Zn load. It is further shown that MT induction can occur within the postprandial period, suggesting that MT is responsive to fluctuations in dietary Zn. ZnD mice had MT inductions 2.5-and 4-fold greater than ZnR mice in the intestine and pancreas. It is a commonly held view that MT synthesis in the small intestine is associated with a reduction in Zn absorption (Cousins 1985) . However, enhanced MT synthesis occurred concurrently with increased Zn absorption in the small intestine of ZnD mice when given the oral dose of 770 nmol of Zn. Moreover, in our previous study we showed that MTϩ/ϩ mice absorbed 80% more Zn (dose of 770 nmol incorporated into an egg-white meal) than MTϪ/Ϫ mice, despite the presence of intestinal MT . Thus, MT appears to enhance Zn absorption in ZnD mice fed intragastric Zn and in ZnR mice fed Zn in a meal. It is possible that the enhanced MT synthesis could reflect a higher flux of Zn through the enterocyte as a result of an upregulation of Zn transport under conditions in which Zn supply is limited. Under such a circumstance, MT could capture Zn in the enteroctye to be later processed for absorption or secretion, or it might facilitate Zn transfer to other ligands within the mucosal cells. Zinc-transporter protein-1 may be important in this regard because it is the Zn transporter which is localized on the basolateral membrane and appears to mediate the efflux of Zn from the enterocyte to the serosa Cousins 1998, Palmiter and Findley 1995) .
The responsiveness of pancreatic MT synthesis to Zn in the ZnD mice needs to be considered in light of the role of the pancreas in Zn secretion (Lönnerdal 1989) . We have previously demonstrated that MT-null mice secrete more 65 Zn from a systemically injected dose and that a major contributor to this extra Zn loss was the pancreas ). The remaining loss was via intestinal mucosal-to-luminal transfer. It can be postulated that the increased responsiveness of MT induction in the pancreas in the ZnD mice may reflect the FIGURE 1 Metallothionein (MT) concentrations in liver (panel A), small intestine (panel B) and pancreas (panel C) of MTϩ/ϩ mice after gastric gavage with varying amounts of Zn. Points represent the means and SEM, n ϭ 5-16. Mice were fed for 7 d on a purified egg-white diet that was either Zn-replete (100 mg of Zn/kg) or Zn-depleted (0.8 mg of Zn/kg). They were then deprived of food for 20 h and gavaged with 65 Zn in selected amounts of ZnSO 4 (154 -1540 nmol) (see the Materials and Methods section). Mice were killed 4 h later, and liver MT was determined by the Cd-hemoglobin affinity assay. MT concentrations in liver and small intestine of Zn-replete mice have previously been published . Differences between means were analyzed by the post-hoc Tukey test using the mean square error derived from ANOVA. * Significantly different from mice fed Zn-replete diets at the same oral Zn dose, P Ͻ 0.05.
